Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Specific therapy in acute liver failure].

Ali Canbay1, Guido Gerken

  • 1Abteilung für Gastroenterologie und Hepatologie, Zentrum für Innere Medizin, Universitätsklinikum Essen.

Medizinische Klinik (Munich, Germany : 1983)
|June 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vancomycin Exposure Dynamics and Clinical Outcomes in Critically Ill Patients: A Retrospective Cohort Study.

Antibiotics (Basel, Switzerland)·2026
Same author

Systematic assessment for potential endogenous normalizers for microRNA analysis in fecal samples.

Scientific reports·2026
Same author

SARS-CoV-2 infection, viral burden, and variant-specific outcomes in hospitalized patients with heart failure.

European journal of internal medicine·2026
Same author

Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma.

Molecular therapy. Oncology·2026
Same author

Are CD4<sup>+</sup> T-Cell Counts Associated with <i>Pneumocystis jirovecii</i> Detection in Hospitalized Patients with Liver Disease? A Retrospective Exploratory Pilot Analysis.

Livers·2026
Same author

Hepatic Steatosis: A Pandemic Disease Causing Serious Secondary Diseases.

Deutsches Arzteblatt international·2026
Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020
Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020
Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020
Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2016
Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2016
Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2014
See all related articles

Acute liver failure, a severe condition with high mortality, involves liver insufficiency and multi-organ response. Targeting apoptosis pathways may offer new treatments for this critical liver injury.

Area of Science:

  • Hepatology and Molecular Biology
  • Cellular Biology
  • Toxicology

Context:

  • Acute liver failure (ALF) is a critical clinical syndrome characterized by severe hepatic insufficiency, hepatorenal syndrome, and encephalopathy.
  • Etiology of ALF varies geographically, with viral hepatitis prevalent globally and drug-induced liver injury (acetaminophen) common in developed nations.
  • The underlying pathology involves widespread hepatocyte apoptosis and/or necrosis, leading to liver injury and organ dysfunction.

Purpose:

  • To summarize the current understanding of acute liver failure, its causes, and pathological mechanisms.
  • To highlight the significance of hepatocyte apoptosis in the pathogenesis of ALF.
  • To explore the potential of targeting apoptosis-related molecules for novel therapeutic strategies.

Summary:

Related Experiment Videos

  • Acute liver failure (ALF) presents with hepatic insufficiency, coagulopathy, hepatorenal syndrome, and encephalopathy, often leading to multi-organ failure and high mortality.
  • While viral hepatitis is a common cause worldwide, drug-induced hepatotoxicity, particularly from acetaminophen, is a leading precipitant in many developed countries.
  • The common pathway for various etiologies involves hepatocyte apoptosis and/or necrosis, driving liver injury and insufficiency.

Impact:

  • Identification of molecular targets in apoptosis pathways could lead to improved prognostic scores for ALF patients.
  • New therapeutic avenues targeting cellular death mechanisms may enhance patient outcomes and survival rates.
  • Understanding the molecular basis of ALF can inform the development of targeted interventions for liver regeneration and protection.